KSKishore Kumar Shil

Kishore Kumar Shil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kishore Kumar Shil has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Ma Hasanat

    Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    2 shared publications
  • Hafsa Mahrukh

    Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh

    1 shared publication
  • Mahmud Hossain

    Rheumatology, Khulna Medical College Hospital, Khulna, BGD

    1 shared publication
  • Mashfiqul Hasan

    Assistant Professor, Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    1 shared publication
  • Muhammad A. Hasanat

    Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh

    1 shared publication
  • Nusrat Sultana

    Assistant Professor, Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    1 shared publication

Latest Publications

  • Open Access

    Lifestyle and Follow-Up Gaps Contribute to Poor Glycemic Control in Patients With Type 2 Diabetes Mellitus in Southwestern Bangladesh

    by Kishore Kumar Shil, Sudipta Bakchi, Susanta K. Paul, Mahmud Hossain

    ​​​Background Type 2 diabetes mellitus (T2DM) is a growing global health concern, particularly in low- and middle-income countries, where the rate of poor glycemic control is high. Lifestyle modifications and regular follow-ups are essential for effective management and prevention of complications. Methodology This cross-sectional study was conducted at a tertiary care facility from March to December 2024, enrolling 360 adults with T2DM using non-probability purposive sampling. Data on demographics, clinical history, and biochemical parameters (glycated hemoglobin (HbA1c), plasma glucose) were collected to assess glycemic control, with an HbA1c threshold of 7%. Ethical approval and informed consent were obtained, and data were analyzed using SPSS version 25 (IBM Corp., Armonk, NY, USA). Results A total of 360 adults with T2DM participated in the study, with a mean age of 48.4 years. Most participants were female (62.7%) and overweight or obese (78%). The median duration of diabetes was five years, and 60% of patients had at least one comorbidity. Poor glycemic control was found in 82.7% based on HbA1c and 90.2% based on plasma glucose. Better glycemic control was significantly associated with factors such as shorter diabetes duration, medication adherence, diabetes education, diet, exercise, and regular follow-up. Logistic regression revealed that age, diabetes duration, diabetic diet (odds ratio (OR) = 5.6), regular exercise (OR = 3.8), and regular follow-up (OR = 8.5) were significantly associated with better glycemic control. Conclusions The study revealed a high prevalence of poor glycemic control among T2DM patients in southwestern Bangladesh. Targeted interventions, especially lifestyle and regular follow-up protocols, are urgently needed to improve diabetes management and prevent complications.


  • Open Access

    Serum resistin increases in gestational diabetes but does not differ among various trimesters

    by Tahmina Ferdousi, Tania Tofail, Sharmin Jahan, Kishore K. Shil, Hafsa Mahrukh, Muhammad A. Hasanat


  • Open Access

    Sex Reversal Syndrome (SRS): A Case of SRY-Positive 46,XX Testicular Disorder

    by Kishore Kumar Shil, Tahmina Ferduosi, Tahniyah Haq, Ma Hasanat

    We report a case of an SRY-positive 46,XX Indian male who presented with small testis and phallus, poor beard and mustache development and gynecomastia at the age of 24 years. He was biochemically found to have hypergonadotropic hypogonadism. He had 46,XX karyotype and Quantitative Fluorescence-PCR (QF-PCR) identified the SRY gene on the X chromosome. SRY-positive 46 XX male SRS cases usually present as phenotypically male since birth but develop features of hypogonadism, poor testicular development, and infertility after puberty. Infertility, hypogonadism, external genital development, and psychological distress are the major concerns during the management of the patients. Testosterone therapy for hypogonadism, artificial reproductive technologies for fertility, surgical repair of hypospadias/cryptorchidism/under-virilized genitalia and psychological and genetic counseling are helpful for proper management of the patients.


  • Open Access

    Higher Glycemic Excursion of Newly Diagnosed Youthonset Type-2 Diabetes Mellitus May Be Related to Â-Cell Secretory Capacity and Not to Insulin Resistance

    by Kishore Kumar Shil, Mashfiqul Hasan, Nusrat Sultana, Sayad Bin Abdus Salam, Ma Hasanat

    Background: Youth-onset type 2 Diabetes mellitus (T2DM) often presents with high glycemic values.To see the plasma glucose and hemoglobin A1c (HBA1c) at diagnosis and their relationship with â-cell secretory capacity and insulin resistance in phenotypic T2DM of young. Methods: This cross-sectional study enrolled 72 newlydiagnosed youth-onset phenotypically T2DM [age range 19-29, median 27, inter-quartile range (IQR) 24-29 years; male 32 (44.4%), female 40 (55.6%)] during March-December’2022 in Endocrinology department, BSMMU. The secretory capacity of â-cell was estimated by fasting C-peptide (measured by chemiluminescence immunoassay) and insulin resistance by calculating visceral adiposity index (VAI) and serum triglyceride/highdensity lipoprotein (TH/HDL) ratio. Results: Median HbA1c, fasting plasma glucose (FPG), and 2h plasma glucose (2h-PG) of the participants were 8.7% (IQR 6.7-11.0), 10.8 (IQR 7.1-16.3) mmol/L and 18.0 (IQR 13.1- 24.3) mmol/L respectively. All glycemic values were negatively correlated to fasting C-peptide (HbA1c: r=-0.437, pConclusion: Higher glycemic excursion at diagnosis of youth-onset T2DM is related to lower â-cells reserve and lower obesity indices but not to insulin resistance. Bangladesh J Medicine 2023; Vol. 34, No. 2(1) Supplement: 214-215